SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-110217
Filing Date
2020-09-30
Accepted
2020-09-30 09:26:13
Documents
12
Period of Report
2020-09-30
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2032112d1_8k.htm   iXBRL 8-K 32849
  Complete submission text file 0001104659-20-110217.txt   210330

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ntrp-20200930.xsd EX-101.SCH 3222
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ntrp-20200930_lab.xml EX-101.LAB 34591
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ntrp-20200930_pre.xml EX-101.PRE 22734
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2032112d1_8k_htm.xml XML 3611
Mailing Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036 (973) 242-0005
Neurotrope, Inc. (Filer) CIK: 0001513856 (see all company filings)

IRS No.: 463522381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38045 | Film No.: 201211034
SIC: 2834 Pharmaceutical Preparations